Determination of paclitaxel in biological fluids by micellar electrokinetic chromatography

被引：70

作者：

Hempel, G ^{[1
]}

Lehmkuhl, D ^{[1
]}

Krumpelmann, S ^{[1
]}

Blaschke, G ^{[1
]}

Boos, J ^{[1
]}

机构：

[1] UNIV MUNSTER,INST PHARMAZEUT CHEM,D-48149 MUNSTER,GERMANY

来源：

JOURNAL OF CHROMATOGRAPHY A | 1996年 / 745卷 / 1-2期

关键词：

paclitaxel; taxol; taxotere;

D O I：

10.1016/0021-9673(96)00351-2

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

A method has been developed for the determination of paclitaxel (Taxol) in plasma and urine using capillary electrophoresis with sodium dodecyl sulfate as additive in the run buffer. The samples are extracted and preconcentrated with tert.-butyl methyl ether. Taxotere has been used as the internal standard. The limit of detection for paclitaxel is 20 ng/ml. In comparison to high-performance liquid chromatography, the capillary electrophoresis method is simple and needs less organic solvents.

引用

页码：173 / 179

页数：7

共 13 条

[1] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND MICELLAR ELECTROKINETIC CHROMATOGRAPHY OF TAXOL AND RELATED TAXANES FROM BARK AND NEEDLE EXTRACTS OF TAXUS SPECIES [J].

CHAN, KC ;

ALVARADO, AB ;

MCGUIRE, MT ;

MUSCHIK, GM ;

ISSAQ, HJ ;

SNADER, KM .

JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 657 (02) :301-306

[2]

ENGELHARDT H, 1994, KAPILLARELEKTROPHORE, P55

[3] NONLINEAR PHARMACOKINETICS AND METABOLISM OF PACLITAXEL AND ITS PHARMACOKINETIC/PHARMACODYNAMIC RELATIONSHIPS IN HUMANS [J].

GIANNI, L ;

KEARNS, CM ;

GIANI, A ;

CAPRI, G ;

VIGANO, L ;

LOCATELLI, A ;

BONADONNA, G ;

EGORIN, MJ .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :180-190

[4] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC PROCEDURES FOR THE QUANTITATIVE-DETERMINATION OF PACLITAXEL (TAXOL) IN HUMAN URINE [J].

HUIZING, MT ;

ROSING, H ;

KOOPMAN, F ;

KEUNG, ACF ;

PINEDO, HM ;

BEIJNEN, JH .

JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 664 (02) :373-382

[5] PHARMACOKINETICS OF PACLITAXEL AND METABOLITES IN A RANDOMIZED COMPARATIVE-STUDY IN PLATINUM-PRETREATED OVARIAN-CANCER PATIENTS [J].

HUIZING, MT ;

KEUNG, ACF ;

ROSING, H ;

VANDERKUIJ, V ;

HUININK, WWT ;

MANDJES, IM ;

DUBBELMAN, AC ;

PINEDO, HM ;

BEIJNEN, JH .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (11) :2127-2135

[6] PHASE-I TRIAL OF PACLITAXEL IN CHILDREN WITH REFRACTORY SOLID TUMORS - A PEDIATRIC-ONCOLOGY-GROUP STUDY [J].

HURWITZ, CA ;

RELLING, MV ;

WEITMAN, SD ;

RAVINDRANATH, Y ;

VIETTI, TJ ;

STROTHER, DR ;

RAGAB, AH ;

PRATT, CB .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (12) :2324-2329

[7]

KEARNS CM, 1995, SEMIN ONCOL, V22, P16

[8]

LONGNECKER SM, 1987, CANCER TREAT REP, V71, P53

[9] ANALYSIS OF ANTICANCER DRUGS IN BIOLOGICAL-FLUIDS - DETERMINATION OF TAXOL WITH APPLICATION TO CLINICAL PHARMACOKINETICS [J].

RIZZO, J ;

RILEY, C ;

VONHOFF, D ;

KUHN, J ;

PHILLIPS, J ;

BROWN, T .

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1990, 8 (02) :159-164

[10]

SHAH VP, 1991, EUR J DRUG METAB PH, V16, P249

← 1 2 →